“…These agents include rapamycin[71],[72], arsenic trioxide (As 2 O 3 ) [73]–[75], temozolomide[76]–[78], kringle domains of plasminogen (endostatin kringle 5 ) [79], phenethyl isothiocyanate (PEITC) [80], OSU-03012 (derivative of celecoxib) [81], NVP-BEZ235[82],[83], and cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guerin (BCG/CWS)[84]. In addition, some autophagic inhibitors, such as 3-MA, chloroquine, bafilomycin A1, tamoxifen, and proteasome inhibitor MG-132[51],[85],[86] (Table 1), also inhibit tumorigenesis by playing a protective role in autophagy.…”